908 Devices Inc.

908 Devices Inc. provides advanced chemical analysis devices that enable real-time detection and identification of chemical substances for safety and security applications in various sectors. Founded in 2012 in Boston, US, 908 Devices Inc. specializes in developing devices for chemical analysis.

The company has completed 9 deals, with its most recent funding round being an IPO on December 17, 2020, raising USD 130 mn. The CEO of the company is Kevin Knopp, who is one of the founders alongside Christopher Brown. 908 Devices specializes in advanced chemical analysis devices designed to detect, identify, and monitor various chemical substances in real-time at the point of need. Their core product offerings include the MX908 and its variants, ProtectIR, VipIR, XplorIR, and ThreatID, all of which utilize analytical technologies and machine learning for rapid chemical identification.

These devices cater to critical sectors such as customs and border protection, explosive ordnance disposal, hazardous materials response, and law enforcement, ensuring safety in operations across North America, Europe, and Asia. In 2023, 908 Devices reported a revenue of USD 50. 23 mn, with an EBITDA of USD -40. 37 mn.

The company primarily generates revenue through sales of its specialized devices and related services to government and law enforcement agencies, focusing on providing advanced chemical detection capabilities. 908 Devices intends to leverage its latest IPO funding of USD 130 mn to support the development of new products and enhance its market reach. The company plans to introduce new variants of its devices and expand into international markets, particularly targeting Europe and Asia over the next few years. The funds will be utilized for research and development as well as marketing initiatives to drive growth in these regions.